Medco 2014 Annual Report Download - page 85
Download and view the complete annual report
Please find page 85 of the 2014 Medco annual report below. You can navigate through the pages in the report by either clicking on the pages listed below, or by using the keyword search tool below to find specific information within the annual report.83
Express Scripts 2014 Annual Report
Stock options and SSRs.ExpressScriptsmaygrantstockoptionsandSSRstocertainofficers,directorsand
employeestopurchasesharesofExpressScriptsHoldingCompanycommonstockatfairmarketvalueonthedateofgrant.
TheSSRsandstockoptionsgrantedunderthe2000LTIP,2011LTIPand2002StockIncentivePlangenerallyhavethree-year
gradedvesting.
Duetothenatureoftheawards,weusethesamevaluationmethodsandaccountingtreatmentsforSSRsandstock
options.AsofDecember31,2014and2013,unearnedcompensationrelatedtoSSRsandstockoptionswas$28.7millionand
$43.8million,respectively.Werecordedpre-taxcompensationexpenserelatedtoSSRsandstockoptionsof$48.0million,
$77.3millionand$220.0millionin2014,2013and2012,respectively.TheincreasefortheyearendedDecember31,2012
resultedfromstock-basedcompensationexpenseaccelerationassociatedwiththeterminationofcertainMedcoemployees.The
weighted-averageremainingrecognitionperiodforstockoptionsandSSRsis1.9years.
AsummaryofthestatusofstockoptionsandSSRsasofDecember31,2014,andchangesduringtheyearended
December31,2014,ispresentedbelow.
Shares
(in millions)
Weighted-
Average Exercise
Price Per Share
Weighted-
Average
Remaining
Contractual Life
(in years)
Aggregate
Intrinsic Value
(in millions)(1)
Outstandingatbeginningofyear 31.9 $43.56
Granted 3.1 76.93
Exercised (13.6)39.92
Forfeited/cancelled (0.8)63.33
Outstandingatendofperiod 20.6 50.26 4.9 $709.0
Awardsexercisableatperiodend 14.5 $44.15 4.5 $589.4
(1) Amountbywhichthemarketvalueoftheunderlyingstockexceedstheexercisepriceoftheoption.
FortheyearsendedDecember31,2014and2013,thewindfalltaxbenefitrelatedtostockoptionsexercisedduring
theyearwas$94.0millionand$42.7million,respectively,andisclassifiedasafinancingcashinflowontheconsolidated
statementofcashflows.
ThefairvalueofstockoptionsandSSRsgrantedisestimatedonthedateofgrantusingaBlack-Scholesmultiple
option-pricingmodelwiththefollowingweighted-averageassumptions:
2014 2013 2012
Expectedlifeofoption 3-5years 4-5years 2-5years
Risk-freeinterestrate 0.7%-1.8% 0.6%-1.7% 0.3%-0.9%
Expectedvolatilityofstock 21%-29% 27%-37% 29%-38%
Expecteddividendyield None None None
Weighted-averagevolatilityofstock 27.4% 34.1% 35.5%
TheBlack-Scholesmodelrequiressubjectiveassumptions,includingfuturestockpricevolatilityandexpectedtime
toexercise,whichgreatlyaffectthecalculatedvalues.Theexpectedtermandforfeiturerateofoptionsgrantedisderivedfrom
historicaldataonemployeeexercisesandpost-vestingemploymentterminationbehavioraswellasexpectedbehavioron
outstandingoptions.Therisk-freerateisbasedontheUnitedStatesTreasuryratesineffectduringthecorrespondingperiodof
grant.Theexpectedvolatilityisbasedonthehistoricalvolatilityofourstockprice.Thesefactorscouldchangeinthefuture,
whichwouldaffectthestock-basedcompensationexpenseinfutureperiods.
Cashproceeds,intrinsicvaluerelatedtototalstockoptionsexercised,andweighted-averagefairvalueofstock
optionsgrantedduringtheyearsendedDecember31,2014,2013and2012areprovidedinthefollowingtable:
(in millions, except per share data) 2014 2013 2012
Proceedsfromstockoptionsexercised $542.4 $524.0 $401.0
Intrinsicvalueofstockoptionsexercised 476.3 362.0 359.6
Weighted-averagefairvaluepershareofoptionsgrantedduringtheyear $17.98 $17.17 $15.13
79